Mammaglobin-A precursor (32-40)

Mammaglobin-A precursor (32-40) is a synthetic peptide fragment derived from the mammaglobin-A protein, which is notably associated with mammary tissue and has gained prominence as a molecular marker in breast cancer research. As a defined segment from the 32nd to the 40th amino acid of the precursor sequence, this peptide offers a reliable tool for exploring the biochemical features, immunogenic properties, and functional roles of mammaglobin-A in both physiological and pathological contexts. Its sequence specificity and structural fidelity make it particularly valuable for applications that require precise molecular recognition, such as antibody development, assay calibration, and mechanistic studies of protein interactions relevant to cancer biology.

Epitope mapping: The defined sequence of the mammaglobin-A (32-40) peptide enables detailed epitope mapping studies, which are critical for identifying antigenic determinants recognized by antibodies. Researchers can use this fragment to delineate the minimal regions necessary for antibody binding, facilitating the development and validation of monoclonal or polyclonal antibodies with high specificity against mammaglobin-A. Such mapping is instrumental in advancing immunoassay design, improving diagnostic reagents, and supporting the generation of targeted research tools for the study of breast tissue biomarkers.

Immunoassay development: The peptide serves as a standard or positive control in the creation and optimization of immunoassays, including ELISA and western blot protocols aimed at detecting mammaglobin-A expression. By incorporating this well-characterized fragment, assay developers can calibrate sensitivity and specificity parameters, validate antibody performance, and ensure reproducibility across experimental batches. This contributes to the reliability of biomarker quantification in research samples, particularly in studies focused on breast cancer detection and tissue profiling.

Peptide-based functional studies: Owing to its defined sequence and origin, the mammaglobin-A (32-40) fragment is employed in functional assays to investigate its role in protein-protein interactions, cellular signaling pathways, or potential involvement in tumorigenic processes. Researchers utilize the peptide to probe the molecular mechanisms underpinning mammaglobin-A's activity, assess its binding partners, and explore its influence on cellular phenotypes in model systems. These studies provide mechanistic insights that can inform broader investigations into breast tissue biology and oncogenic signaling.

Antibody screening and validation: The peptide is widely used as a reference antigen in the screening and validation of newly generated antibodies intended for mammaglobin-A detection. By serving as a test substrate, it allows for the rapid assessment of antibody affinity, specificity, and cross-reactivity, thereby ensuring that only the most reliable reagents are selected for downstream research applications. This process is particularly valuable in the context of developing diagnostic tools or research-grade detection kits where antibody performance is paramount.

Quality control in peptide synthesis: As a representative synthetic fragment, the mammaglobin-A (32-40) peptide is also utilized in quality control protocols for peptide manufacturing and analytical method development. Its well-defined sequence and physicochemical properties make it suitable for use as a calibration standard in high-performance liquid chromatography (HPLC), mass spectrometry, and other analytical platforms. This aids in verifying the accuracy of peptide synthesis processes, monitoring batch consistency, and establishing robust quality assurance benchmarks for research-use peptides.

1. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

2. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

3. TMEM16F and dynamins control expansive plasma membrane reservoirs

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes